NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hand Sanitizer | ALCOHOL | Giant Eagle | d384d3f3-a3c8-a98d-e053-2995a90ab9bf | 2026-05-07 | Warnings | 3K9958V90M |
| Infants Pain and Fever Cherry Flavor | ACETAMINOPHEN | Genexa Inc. | 19215ea7-d55f-8d81-e063-6294a90a4924 | 2026-05-07 | Warnings | 362O9ITL9D |
| Sterile Water | WATER | Hospira, Inc. | 3a6422e1-feee-4095-8883-2b0837039e6e | 2026-05-07 | Warnings, Adverse reactions | 059QF0KO0R |
| MENSTRUAL RELIEF | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | a44a5cf4-e88a-4da9-907a-8d8497c7d79d | 2026-05-07 | Warnings | 362O9ITL9D |
| up and up acetaminophen infants | ACETAMINOPHEN | Target Corporation | c1dd8330-fb6b-4d1f-9484-c199dc69214d | 2026-05-07 | Warnings | 362O9ITL9D |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5569d607-f1cb-4f1d-8a00-d50433ec05d3 | 2026-05-07 | Warnings, Adverse reactions | YKH834O4BH |
| Nighttime Sleep Aid | DIPHENHYDRAMINE HCL | Strategic Sourcing Services LLC | e68d96c8-21c5-406c-b22c-3e384027c79f | 2026-05-07 | Warnings | TC2D6JAD40 |
| Childrens Allergy Relief | DIPHENHYDRAMINE HCL | Walgreen Company | 4856cd7b-ccdf-4546-9c65-236ebaac3dca | 2026-05-06 | Warnings | TC2D6JAD40 |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | Q40Q9N063P R16CO5Y76E G59M7S0WS3 |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 4.5N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 67b90f00-4c82-40cd-af96-f8dedf95f8af | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 4W Warm | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 7a2bd17d-0ea7-4326-9939-a747869c01d2 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 4N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | a396c0eb-f91f-4732-9c20-6b25aa0634b7 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 6N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 18b21fba-f6ee-4ac5-a536-096716f51da0 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 1N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 13c34bba-f939-4aa7-9457-9d6025902e06 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 3CR Cool Rosy | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | d12905b6-97aa-429a-8800-23856fe31f06 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 0N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 43599d17-81f4-4c6e-b6bd-d1e700b668ee | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 0.5N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 116f09db-f859-40c5-8857-33503903ee76 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 2N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 480e5bf9-8e24-4335-a434-93255ceb640e | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 1.5N Neutral | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 7057feab-20fe-4547-8223-0816904bcfd6 | 2026-05-06 | Warnings | 15FIX9V2JP |
| Dior Backstage Glow-Up Skin Tint Tinted Moisturizer SPF 20 1CR Cool Rosy | OCTISALATE, TITANIUM DIOXIDE | Parfums Christian Dior | 672a804d-ba8e-4c03-91fc-3edc0b12c627 | 2026-05-06 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.